220 related articles for article (PubMed ID: 37191809)
21. Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Vargas-Hernández A; Mace EM; Zimmerman O; Zerbe CS; Freeman AF; Rosenzweig S; Leiding JW; Torgerson T; Altman MC; Schussler E; Cunningham-Rundles C; Chinn IK; Carisey AF; Hanson IC; Rider NL; Holland SM; Orange JS; Forbes LR
J Allergy Clin Immunol; 2018 Jun; 141(6):2142-2155.e5. PubMed ID: 29111217
[TBL] [Abstract][Full Text] [Related]
22. Introduction: Cancer Gene Networks.
Clarke R
Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
[TBL] [Abstract][Full Text] [Related]
23. Biallelic TP53 gain of function mutations in rapidly progressing solid tumors.
Sande CM; Chang B; Monga V; Bossler AD; Ma D
Cancer Genet; 2018 Apr; 222-223():20-24. PubMed ID: 29666004
[TBL] [Abstract][Full Text] [Related]
24. Multiomics Network Medicine Approaches to Precision Medicine and Therapeutics in Cardiovascular Diseases.
Wang RS; Maron BA; Loscalzo J
Arterioscler Thromb Vasc Biol; 2023 Apr; 43(4):493-503. PubMed ID: 36794589
[TBL] [Abstract][Full Text] [Related]
25. Synaptic Dysfunction by Mutations in
Elmasri M; Lotti JS; Aziz W; Steele OG; Karachaliou E; Sakimura K; Hansen KB; Penn AC
Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741674
[No Abstract] [Full Text] [Related]
26. Gain-of-function mutant p53 in cancer progression and therapy.
Zhang C; Liu J; Xu D; Zhang T; Hu W; Feng Z
J Mol Cell Biol; 2020 Sep; 12(9):674-687. PubMed ID: 32722796
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevance of gain-of-function mutations of p53 in high-grade serous ovarian carcinoma.
Kang HJ; Chun SM; Kim KR; Sohn I; Sung CO
PLoS One; 2013; 8(8):e72609. PubMed ID: 23967324
[TBL] [Abstract][Full Text] [Related]
28. Elucidating the molecular and developmental biology of parasitic nematodes: Moving to a multiomics paradigm.
Ma G; Wang T; Korhonen PK; Hofmann A; Sternberg PW; Young ND; Gasser RB
Adv Parasitol; 2020; 108():175-229. PubMed ID: 32291085
[TBL] [Abstract][Full Text] [Related]
29. e-MutPath: computational modeling reveals the functional landscape of genetic mutations rewiring interactome networks.
Li Y; Burgman B; Khatri IS; Pentaparthi SR; Su Z; McGrail DJ; Li Y; Wu E; Eckhardt SG; Sahni N; Yi SS
Nucleic Acids Res; 2021 Jan; 49(1):e2. PubMed ID: 33211847
[TBL] [Abstract][Full Text] [Related]
30. Precision medicine in the treatment of primary immunodeficiency diseases.
Leiding JW; Ballow M
Curr Opin Allergy Clin Immunol; 2018 Apr; 18(2):159-166. PubMed ID: 29406361
[TBL] [Abstract][Full Text] [Related]
31. Functional evaluation of epilepsy-associated KCNT1 variants in multiple cellular systems reveals a predominant gain of function impact on channel properties.
Hinckley CA; Zhu Z; Chu JH; Gubbels C; Danker T; Cherry JJ; Whelan CD; Engle SJ; Nguyen V
Epilepsia; 2023 Aug; 64(8):2126-2136. PubMed ID: 37177976
[TBL] [Abstract][Full Text] [Related]
32. Noonan syndrome/leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN11) enhance cell migration and angiogenesis.
Wang S; Yu WM; Zhang W; McCrae KR; Neel BG; Qu CK
J Biol Chem; 2009 Jan; 284(2):913-20. PubMed ID: 19008228
[TBL] [Abstract][Full Text] [Related]
33. Systems Immunology Analyses of
Kaviany S; Bartkowiak T; Dulek DE; Khan YW; Hayes MJ; Schaefer SG; Ye X; Dahunsi DO; Connelly JA; Irish JM; Rathmell JC
Immunohorizons; 2022 Jul; 6(7):447-464. PubMed ID: 35840326
[TBL] [Abstract][Full Text] [Related]
34. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.
Leiding JW; Vogel TP; Santarlas VGJ; Mhaskar R; Smith MR; Carisey A; Vargas-Hernández A; Silva-Carmona M; Heeg M; Rensing-Ehl A; Neven B; Hadjadj J; Hambleton S; Ronan Leahy T; Meesilpavikai K; Cunningham-Rundles C; Dutmer CM; Sharapova SO; Taskinen M; Chua I; Hague R; Klemann C; Kostyuchenko L; Morio T; Thatayatikom A; Ozen A; Scherbina A; Bauer CS; Flanagan SE; Gambineri E; Giovannini-Chami L; Heimall J; Sullivan KE; Allenspach E; Romberg N; Deane SG; Prince BT; Rose MJ; Bohnsack J; Mousallem T; Jesudas R; Santos Vilela MMD; O'Sullivan M; Pachlopnik Schmid J; Průhová Š; Klocperk A; Rees M; Su H; Bahna S; Baris S; Bartnikas LM; Chang Berger A; Briggs TA; Brothers S; Bundy V; Chan AY; Chandrakasan S; Christiansen M; Cole T; Cook MC; Desai MM; Fischer U; Fulcher DA; Gallo S; Gauthier A; Gennery AR; Gonçalo Marques J; Gottrand F; Grimbacher B; Grunebaum E; Haapaniemi E; Hämäläinen S; Heiskanen K; Heiskanen-Kosma T; Hoffman HM; Gonzalez-Granado LI; Guerrerio AL; Kainulainen L; Kumar A; Lawrence MG; Levin C; Martelius T; Neth O; Olbrich P; Palma A; Patel NC; Pozos T; Preece K; Lugo Reyes SO; Russell MA; Schejter Y; Seroogy C; Sinclair J; Skevofilax E; Suan D; Suez D; Szabolcs P; Velasco H; Warnatz K; Walkovich K; Worth A; ; Seppänen MRJ; Torgerson TR; Sogkas G; Ehl S; Tangye SG; Cooper MA; Milner JD; Forbes Satter LR
J Allergy Clin Immunol; 2023 Apr; 151(4):1081-1095. PubMed ID: 36228738
[TBL] [Abstract][Full Text] [Related]
35. Dysregulated IFN-γ signals promote autoimmunity in STAT1 gain-of-function syndrome.
Largent AD; Lambert K; Chiang K; Shumlak N; Liggitt D; Oukka M; Torgerson TR; Buckner JH; Allenspach EJ; Rawlings DJ; Jackson SW
Sci Transl Med; 2023 Jul; 15(703):eade7028. PubMed ID: 37406138
[TBL] [Abstract][Full Text] [Related]
36. TP53 gain-of-function mutation promotes inflammation in glioblastoma.
Ham SW; Jeon HY; Jin X; Kim EJ; Kim JK; Shin YJ; Lee Y; Kim SH; Lee SY; Seo S; Park MG; Kim HM; Nam DH; Kim H
Cell Death Differ; 2019 Mar; 26(3):409-425. PubMed ID: 29786075
[TBL] [Abstract][Full Text] [Related]
37. Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations.
Meng X; Yang S; Li Y; Li Y; Devor EJ; Bi J; Wang X; Umesalma S; Quelle DE; Thiel WH; Thiel KW; Leslie KK
Dis Markers; 2018; 2018():3810108. PubMed ID: 30647797
[TBL] [Abstract][Full Text] [Related]
38. TP53 Gain-of-Function Mutation is a Poor Prognostic Factor in High-Methylated Metastatic Colorectal Cancer.
Wakayama S; Ouchi K; Takahashi S; Yamada Y; Komatsu Y; Shimada K; Yamaguchi T; Shirota H; Takahashi M; Ishioka C
Clin Colorectal Cancer; 2023 Sep; 22(3):327-338. PubMed ID: 37355363
[TBL] [Abstract][Full Text] [Related]
39. Effects of a leukemia-associated gain-of-function mutation of SHP-2 phosphatase on interleukin-3 signaling.
Yu WM; Daino H; Chen J; Bunting KD; Qu CK
J Biol Chem; 2006 Mar; 281(9):5426-34. PubMed ID: 16371368
[TBL] [Abstract][Full Text] [Related]
40. KCNQ2/3 Gain-of-Function Variants and Cell Excitability: Differential Effects in CA1 versus L2/3 Pyramidal Neurons.
Varghese N; Moscoso B; Chavez A; Springer K; Ortiz E; Soh H; Santaniello S; Maheshwari A; Tzingounis AV
J Neurosci; 2023 Sep; 43(38):6479-6494. PubMed ID: 37607817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
